MedPath

Efficacy of Chemical peeling versus Cryotherapy in the Treatment of Solar Lentigo

Not Applicable
Conditions
other melanin hyperpigmentation
Solar lentigo.
Registration Number
IRCT138904084269N1
Lead Sponsor
Research Vice-chancellor of Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
35
Inclusion Criteria

solar lentigo of face or hand
Exclusion criteria: wart, recurrent herpes, sensitivity to light, raynaud phenomenon, pregnancy, lactation, sunburn within recent 2-3 days, those who have received treatments such as surgery, cryotherapy, radiotherapy or PUVA therapy within the last 6 weeks or Isotretinoin during last 6 months

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ightening of lesions. Timepoint: 2 months after treatment. Method of measurement: clinical.
Secondary Outcome Measures
NameTimeMethod
Side effects: Permanent & severe pain, Blister, Permanent erythema & edema, hyperpigmentation, hypopigmentation, scar. Timepoint: Every month. Method of measurement: clinical.
© Copyright 2025. All Rights Reserved by MedPath